Drug Trials and Vaccine - Clinical Research Informer

JPM23: Vaccine developers as dealmakers, Gilead’s trial tea leaves and building platform companies

Bio Pharma Dive

JANUARY 10, 2023

Moderna’s Stéphane Bancel and Pfizer’s Albert Bourla hinted Monday at greater dealmaking to come for their companies, while Gilead gave investors an update on an important cancer drug trial.

Trials

Trials Drug Trials Development Vaccination

McMaster drug trial receives more than $6m to test smallpox vaccine against mpox

Pharma Times

AUGUST 15, 2024

Children accounted for the majority of mpox cases and deaths in the DRC since June 2023

Drug Trials

Drug Trials Vaccination Vaccine Trials

STAT+: Pfizer scraps half of participants in Lyme disease drug trial due to quality issues

STAT News

FEBRUARY 17, 2023

Pfizer and partner Valneva are scrapping data from roughly half of the participants in a Phase 3 trial of a Lyme disease vaccine candidate after uncovering quality issues with a third-party clinical trial operator.

Trials

Trials Drug Trials Clinical Trials Clinical Trials

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy

XTalks

APRIL 26, 2021

After years of disappointing malaria vaccine trials, a malaria shot developed by researchers at the Jenner Institute at the University of Oxford has demonstrated an unprecedentedly high efficacy of 77 percent, and may be the magic bullet the world has been waiting for against the deadly disease.

Vaccination

Vaccination Vaccine Immune Response Trials

HCP’s use of social media: the good and the not so good

World of DTC Marketing

AUGUST 9, 2021

Doximity was flagged for having anti-vaccine information. The best approach is to use social media to connect HCPs to clincial information and drug trials. 86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs.

Nurses

Nurses Marketing Pharma Companies Production

Mathematical models and computer simulations are the new frontiers in COVID-19 drug trials

Scienmag

JULY 18, 2021

The models allow for virtual trials of drugs and vaccines, opening the possibility of pre-assessment for drug and vaccine efficacy against the virus. Researchers are using computer models to simulate COVID-19 infections on a cellular level – the basic structural level of the human body.

Trials

Trials Drug Trials Drugs Vaccination

Scepticism in press over Kintor’s COVID-19 US drug trial

pharmaphorum

MAY 14, 2021

Reuters also pointed to other links with one of the study authors and Brazil’s vaccine sceptic president, Jair Bolsonaro. Kintor is in talks with the Brazilian health regulator Anvisa about a further trials. The post Scepticism in press over Kintor’s COVID-19 US drug trial appeared first on.

Drug Trials

Drug Trials Trials Drugs Dermatology

Grand Rounds July 29, 2022: Effect of Early Treatment With Single-Dose Pegylated Interferon Lambda Among Patients With COVID-19: Results From The TOGETHER Trial (Edward Mills, PhD, FRCP; Jeffrey S. Glenn, MD, PhD)

Rethinking Clinical Trials

AUGUST 4, 2022

The trial has enrolled 1,900 high-risk non-hospitalized and 84% of patients were vaccinated to some extent, from July 2021-Feb 2022. It was a big treatment effect observed in a predominantly vaccinated population.

Trials

Trials Vaccine Vaccination Clinical Trials

Treatment for all: the key steps to better representation in pharma

pharmaphorum

SEPTEMBER 27, 2021

As the vaccines were developed and rolled out, the disparity in their take up among different sections of the community highlighted how excluded some minority communities felt from areas of healthcare. Vaccine hesitancy was the most recent and highest profile example of distrust among minority groups towards the pharmaceutical industry.

Clinical Trials

Clinical Trials Clinical Trials Trials Vaccine

Advancement through adversity: how Covid-driven innovations are becoming best practices for pharmacovigilance

Pharmaceutical Technology

SEPTEMBER 7, 2022

Among the many effects the Covid-19 pandemic has had on the pharmaceutical industry is a substantial increase in the number of AEs being reported from drug trials, due to the fast-tracked development, approval and marketing of vaccines for the SARS-CoV-2 virus. It has translated more than 6.3

Engineer

Engineer Production Medicine Trials

Steps to building a more patient-centric industry

pharmaphorum

DECEMBER 1, 2022

According to the FDA’s 2020 Drug Trials Snapshot Report , only 8% of clinical trial participants are Black or African American, as compared to nearly 14% of the US population. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate.

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Research

What DTC marketers can learn from people who refuse a COVID vaccination

World of DTC Marketing

JULY 19, 2021

SUMMARY: Even though the Delta variant of COVID is highly contagious, people are still choosing not to get vaccinated. Concerns about safety, fear of unknown side effects, and misinformation about COVID-19 are some reasons why people may not accept the vaccine. The media stories about the FDA.

Vaccination

Vaccination Vaccine Marketing Drugs

Phases of Clinical Research: A Detailed Overview

Advarra

JUNE 27, 2023

Some Phase I trials are also first-in-human (FIH) studies, meaning the treatment has not previously been tested in people. Clinical trial data is also important for disease prevention. For example, current prevention research includes the development of vaccines against diseases caused by Zika and Ebola viruses.

Clinical Research

Clinical Research Research Clinical Trials Clinical Trials

Why Black People Remain Underrepresented in Clinical Trials

XTalks

FEBRUARY 25, 2022

Despite these statistics, in the US, Black people only constitute five percent of all clinical trial participants. The overwhelming majority of trial participants nationwide are white. This mistrust stems from both historic and continuing events in healthcare pertaining to issues of racial and socioeconomic discrimination.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Can your LNP manufacturing platform cope with the pace of the mRNA revolution?

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022.

Manufacturing

Manufacturing RNA Contamination Vaccination

Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials

The Pharma Data

MAY 17, 2021

Covid-19 Drugmakers Take On Your Favorite TV Shows to Tackle Vaccine Hesitancy ( WSJ ). Regeneron resumes enrollment in lymphoma drug trials ( Reuters ). Incyte’s vitiligo treatment meets main goal in late-stage trial ( Reuters ). In Focus: US. Now they fear an increase.

Trials

Trials Vaccination Vaccine Scientist

Clinical Research Informer

JPM23: Vaccine developers as dealmakers, Gilead’s trial tea leaves and building platform companies

McMaster drug trial receives more than $6m to test smallpox vaccine against mpox

Webinars

Trending Sources

STAT+: Pfizer scraps half of participants in Lyme disease drug trial due to quality issues

Webinars

Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy

HCP’s use of social media: the good and the not so good

Mathematical models and computer simulations are the new frontiers in COVID-19 drug trials

Scepticism in press over Kintor’s COVID-19 US drug trial

Grand Rounds July 29, 2022: Effect of Early Treatment With Single-Dose Pegylated Interferon Lambda Among Patients With COVID-19: Results From The TOGETHER Trial (Edward Mills, PhD, FRCP; Jeffrey S. Glenn, MD, PhD)

Treatment for all: the key steps to better representation in pharma

Advancement through adversity: how Covid-driven innovations are becoming best practices for pharmacovigilance

Steps to building a more patient-centric industry

What DTC marketers can learn from people who refuse a COVID vaccination

Phases of Clinical Research: A Detailed Overview

Why Black People Remain Underrepresented in Clinical Trials

Can your LNP manufacturing platform cope with the pace of the mRNA revolution?

Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials

Stay Connected